Home › Kanser sa Ovary › Utah › Salt Lake City
Pag-aaral pangklinika para sa Kanser sa Ovary sa Salt Lake City, UT
19 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Salt Lake City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Nagre-recruitPhase 2/3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Intermountain Health, Salt Lake City
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- Huntsman Cancer Institute, Salt Lake City
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 2
- Utah Cancer Specialists, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- Utah Cancer Specialists, Salt Lake City
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Nagre-recruitPhase 1
- START Mountain, Salt Lake City
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Nagre-recruit
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Utah Cancer Specialists, Salt Lake City
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Nagre-recruitPhase 3
- Utah Cancer Specialists Network, Salt Lake City
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Huntsman Cancer Institute, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Nagre-recruitPhase 1
- LDS Hospital, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Salt Lake City
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Salt Lake City
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Melanoma21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Obesity18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
- Kanser sa Prostate15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.